craft-sa-dev Home  

PMC:1584416 / 5142-5429 JSONTXT 4 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T1148 1-2 . denotes .
T1149 2-283 sentence denotes However, the identification in recent years of XP complementation group D patients with atypical disease presentation, including symptoms of both XP and TTD [8], casts doubt on the ability of such a monoallelic paradigm to explain clinical heterogeneity in compound heterozygotes.
T1150 3-10 RB denotes However
T1152 10-12 , denotes ,
T1153 12-15 DT denotes the
T1154 16-30 NN denotes identification
T1155 31-33 IN denotes in
T1156 34-40 JJ denotes recent
T1157 41-46 NNS denotes years
T1158 47-49 IN denotes of
T1159 50-52 NN denotes XP
T1161 53-68 NN denotes complementation
T1162 69-74 NN denotes group
T1163 75-76 NN denotes D
T1160 77-85 NNS denotes patients
T1164 86-90 IN denotes with
T1165 91-99 JJ denotes atypical
T1167 100-107 NN denotes disease
T1166 108-120 NN denotes presentation
T1168 120-122 , denotes ,
T1169 122-131 VBG denotes including
T1170 132-140 NNS denotes symptoms
T1171 141-143 IN denotes of
T1172 144-148 CC denotes both
T1173 149-151 NN denotes XP
T1174 152-155 CC denotes and
T1175 156-159 NN denotes TTD
T1176 160-161 -LRB- denotes [
T1177 161-162 CD denotes 8
T1178 162-163 -RRB- denotes ]
T1179 163-165 , denotes ,
T1151 165-170 VBZ denotes casts
T1180 171-176 NN denotes doubt
T1181 177-179 IN denotes on
T1182 180-183 DT denotes the
T1183 184-191 NN denotes ability
T1184 192-194 IN denotes of
T1185 195-199 JJ denotes such
T1187 200-201 DT denotes a
T1188 202-213 JJ denotes monoallelic
T1186 214-222 NN denotes paradigm
T1189 223-225 TO denotes to
T1190 226-233 VB denotes explain
T1191 234-242 JJ denotes clinical
T1192 243-256 NN denotes heterogeneity
T1193 257-259 IN denotes in
T1194 260-268 NN denotes compound
T1195 269-282 NNS denotes heterozygotes
T1196 282-283 . denotes .
R797 T1150 T1151 advmod However,casts
R798 T1152 T1151 punct ", ",casts
R799 T1153 T1154 det the,identification
R800 T1154 T1151 nsubj identification,casts
R801 T1155 T1154 prep in,identification
R802 T1156 T1157 amod recent,years
R803 T1157 T1155 pobj years,in
R804 T1158 T1157 prep of,years
R805 T1159 T1160 compound XP,patients
R806 T1160 T1158 pobj patients,of
R807 T1161 T1160 compound complementation,patients
R808 T1162 T1163 compound group,D
R809 T1163 T1160 compound D,patients
R810 T1164 T1160 prep with,patients
R811 T1165 T1166 amod atypical,presentation
R812 T1166 T1164 pobj presentation,with
R813 T1167 T1166 compound disease,presentation
R814 T1168 T1166 punct ", ",presentation
R815 T1169 T1166 prep including,presentation
R816 T1170 T1169 pobj symptoms,including
R817 T1171 T1170 prep of,symptoms
R818 T1172 T1173 preconj both,XP
R819 T1173 T1171 pobj XP,of
R820 T1174 T1173 cc and,XP
R821 T1175 T1173 conj TTD,XP
R822 T1176 T1177 punct [,8
R823 T1177 T1154 parataxis 8,identification
R824 T1178 T1177 punct ],8
R825 T1179 T1151 punct ", ",casts
R826 T1180 T1151 dobj doubt,casts
R827 T1181 T1151 prep on,casts
R828 T1182 T1183 det the,ability
R829 T1183 T1181 pobj ability,on
R830 T1184 T1183 prep of,ability
R831 T1185 T1186 amod such,paradigm
R832 T1186 T1184 pobj paradigm,of
R833 T1187 T1186 det a,paradigm
R834 T1188 T1186 amod monoallelic,paradigm
R835 T1189 T1190 aux to,explain
R836 T1190 T1183 acl explain,ability
R837 T1191 T1192 amod clinical,heterogeneity
R838 T1192 T1190 dobj heterogeneity,explain
R839 T1193 T1190 prep in,explain
R840 T1194 T1195 compound compound,heterozygotes
R841 T1195 T1193 pobj heterozygotes,in
R842 T1196 T1151 punct .,casts